
Reduction in antimicrobial use following implementation of a computerized medical record associated with a decrease in rate of Clostridium difficile infection
Paul P. Cook, MD

Evaluation of Daptomycin Activity Tested against 35,058 Bacterial Strains from Hospitalized Patients: Summary of a 7 Year Surveillance Program for North America (2002-2008)
Helio Sader, MD

Telavancin (TLV) Activity Tested Against Gram-Positive (GP) Pathogens Responsible for Bloodstream Infections (BSI) Collected during a Global Surveillance Program (2007-2008)
Helio Sader, MD

Activity of Telavancin (TLV) and Comparator Agents Tested against Gram-Positive (GP) Isolates Cultured from Skin and Skin Structure Infections (SSSI)
Helio Sader, MD

The Effect of Acyclovir on the Prevalence of Bacterial Vaginosis in HIV-1/HSV-2 Co-infected Women Taking Highly Active Antiretroviral Therapy (HAART)
Jenny McManus

Clinical Application of Real-time Quantitative Epstein-Barr Virus > (EBV) Polymerase Chain Reaction Assay to Posttransplant Infection
Amy Karger, MD

A Case-Centered Approach to Investigate the Association between Immunizations and Pediatric Encephalitis in California
Barbara A. Pahud, MD MPH

Dose Response Effects of BIO-K+CL-1285® on Antibiotic-Associated Diarrhea (AAD) and Incidence of Clostridium Difficile (C.Diff.)
Mohamed Mubasher, PhD

144-Week Efficacy and Safety of Raltegravir (RAL) in Treatment-Experienced Patients
Charles John Gonzalez, MD

Enhanced Room Temperature (RT) Stability of Doripenem (DOR) within Two Infusion Devices
Jared L. Crandon, PharmD

A Double-Blind Randomized Trial of a 3-Day Course of Cefpodoxime (CEF) versus Ciprofloxacin (CIP) for Acute Uncomplicated Cystitis (AUC)
Thomas M. Hooten, MD, FIDSA

An Endogenous Antimicrobial Protein with Efficacy Against Multi-Drug-Resistant Gram-Negative Bacteria: The Bactericidal/Permeability-Increasing Protein
Nicole M. Iovine, MD, PhD
